Detection of hepatitis viruses in dendritic cells by in situ PCR.
通过原位 PCR 检测树突状细胞中的肝炎病毒。
基本信息
- 批准号:10670482
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have already reported the defective function of splenic dendritic cells in hepatitis B virus (HBV)-transgenic mouse (Tg), a murine model of human chronic HBV-carrier state. Moreover, a role of dysfunction of dendritic cells have been shown in human hepatitis C virus infection. However, the mechanism underlying the functional defects of dendritic cells could not be clarified in full detail and it is unknown whether dendritic cells are infected with hepatitic viruses or dendritic cells act as a vehicle for the replication of these viruses.In this context, existence of HBV-DNA in dendritic cells and peripheral blood mononuclear cells (PBMC) was examined in patients infected with HBV by PCR and in situ PCR hybridization. In order to optimize the experimental conditions, first we used mononuclear cells from spleen of HBV-Tg as positive controls and undertook a series of preliminary experiments. HBV-DNA was reproducibly detected in HBV-Tg spleen cells using this methods. HBV-DNA was visua … More lized in almost all of the nuclei of spleen cells from HBV-Tg.Next, dendritic cells and PBMC were obtained from patients with chronic hepatitis B. Dendritic cells were isolated from the peripheral blood following a 8 days enrichment procedure in GM-CSF and IL-4. DNA was extracted from dendritic cells and PBMC from patients with chronic hepatitis B, and PCR was done using PCR primers specific for HBV. HBV-DNA was detected in both dendritic cells and PBMC from patients with chronic hepatitis. However, HBV-DNA was not stably detectable in human dendritic cells and PBMC by this method because the structure of these cells were distorted during the manipulation of cells for in situ PCR methodology.Further study is needed to clarify the infectivity of dendritic cells by HBV in human HBV-carriers. The effect of existence of HBV in dendritic cells also need in situ PCR and immunological investigations. However, our data has provided a direct evidence that human peripheral blood dendritic cells is either infected with HEV or HEV is attached to dendritic cells in patients with chronic hepatitis B. Less
我们已经报道了乙型肝炎病毒(HBV)转基因小鼠(Tg)脾树突状细胞功能缺陷,这是一种人类慢性HBV携带者状态的小鼠模型。此外,树突状细胞功能障碍在人类丙型肝炎病毒感染中的作用已被证实。然而,树突状细胞功能缺陷的机制尚不清楚,也不清楚树突状细胞是否感染了肝炎病毒,还是树突状细胞作为这些病毒复制的载体。在此背景下,通过PCR和原位PCR杂交检测HBV感染患者树突状细胞和外周血单核细胞(PBMC)中HBV- dna的存在。为了优化实验条件,我们首先以HBV-Tg患者脾脏单个核细胞为阳性对照,进行了一系列初步实验。该方法可在HBV-Tg脾细胞中重复性检测HBV-DNA。HBV-DNA在几乎所有的脾细胞核中都可见。接下来,从慢性乙型肝炎患者身上获得树突状细胞和PBMC,经过8天的GM-CSF和IL-4富集程序,从外周血中分离出树突状细胞。从慢性乙型肝炎患者的树突状细胞和PBMC中提取DNA,并使用HBV特异性PCR引物进行PCR。在慢性肝炎患者的树突状细胞和PBMC中均检测到HBV-DNA。然而,这种方法在人树突状细胞和PBMC中不能稳定地检测到HBV-DNA,因为这些细胞的结构在原位PCR方法中被扭曲。需要进一步的研究来阐明HBV对人类HBV携带者树突状细胞的感染性。乙型肝炎病毒在树突状细胞中存在的影响还需要原位PCR和免疫学研究。然而,我们的数据提供了直接证据,证明慢性乙型肝炎患者的人外周血树突状细胞要么被HEV感染,要么HEV附着在树突状细胞上
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tanimoto K, Akbar SMF, Michitaka K, Onji M: "Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis ; highly restricted distribution of CD83-positive dendritic cells"Pathology Research amd Practi
Tanimoto K、Akbar SMF、Michitaka K、Onji M:“原发性胆汁性肝硬化患者肝脏中抗原呈递细胞的免疫组织化学定位;CD83 阳性树突状细胞的分布高度受限”病理学研究与实践
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kojima N,Horiike N,Michitaka K,Onji M.: "In situ detection of mutated hepatitis B virus in microdissected, formalin-fixed liver tissues from patients with chronic hepatitis B"Journal of Hepatology. 30. 359-365 (1999)
Kojima N、Horiike N、Michitaka K、Onji M.:“慢性乙型肝炎患者的显微解剖、福尔马林固定肝组织中突变乙型肝炎病毒的原位检测”肝脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kojima N,Horiike N,Michitaka K,Onji M.: "In situ detection of mutated hepatitis B virus in microdissected,formalin-fixed liver tissues from patients with chronic hepati"Journal of Hepatology. 30. 359-365 (1999)
Kojima N、Horiike N、Michitaka K、Onji M.:“慢性肝炎患者的显微解剖、福尔马林固定肝组织中突变乙型肝炎病毒的原位检测”肝脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Onji M,Shinomiya M,Masumoto T,Yamauchi Y,Yamamoto K,Horiike N,Michitaka K,Akabar SMF.: "Dendritic cells in the liver of patients with primary biliary cirrhisis"Dendritic cells. 8. 7-9 (1998)
Onji M、Shinomiya M、Masumoto T、Yamauchi Y、Yamamoto K、Horiike N、Michitaka K、Akabar SMF.:“原发性胆汁性肝硬化患者肝脏中的树突状细胞”树突状细胞。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Akbar SMF, Yamamoto K, Abe M, Ninomiya T, Tanimoto K, Masumoto T, Michitaka K, et al.: "Potent synergic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier"European Journal of Clinical Investiga
Akbar SMF、Yamamoto K、Abe M、Ninomiya T、Tanimoto K、Masumoto T、Michitaka K 等人:“在乙型肝炎小鼠模型的疫苗治疗过程中,草药 sho-saiko-to 具有强大的协同作用
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHITAKA Kojiro其他文献
MICHITAKA Kojiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHITAKA Kojiro', 18)}}的其他基金
Molecular epidemiologic study of the spread of hepatitis B virus genotype D in Japan.
D 基因型乙型肝炎病毒在日本传播的分子流行病学研究。
- 批准号:
17590653 - 财政年份:2005
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Elucidating type 1 conventional dendritic cell-dependent anti-tumour immune responses in brain metastases
阐明脑转移瘤中 1 型传统树突状细胞依赖性抗肿瘤免疫反应
- 批准号:
MR/Y013328/1 - 财政年份:2024
- 资助金额:
$ 1.28万 - 项目类别:
Research Grant
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
浆细胞样树突状细胞发育和功能的分子控制
- 批准号:
10583989 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Intestinal Microbiota Affect Stroke Outcome by Modulating the Dendritic Cell-regulatory T Cell Axis
肠道微生物群通过调节树突状细胞调节 T 细胞轴影响中风结果
- 批准号:
10751249 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
The Effect Of Malaria Parasites On Dendritic Cell Metabolism (TEMPODM)
疟原虫对树突状细胞代谢的影响 (TEMPODM)
- 批准号:
BB/X00029X/1 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Research Grant
The Impact of Metastatic Site On Dendritic Cell-Driven Tumor Immunity
转移部位对树突状细胞驱动的肿瘤免疫的影响
- 批准号:
10738428 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Probing the effect of dendritic cell co-stimulatory ligand lateral mobility on T cell mediated immunity and tolerance
探讨树突状细胞共刺激配体横向移动对T细胞介导的免疫和耐受的影响
- 批准号:
BB/X015408/1 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Research Grant
Dendritic cell targeting by bacterial LysM proteins to suppress inflammation
树突状细胞通过细菌 LysM 蛋白靶向抑制炎症
- 批准号:
10750594 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Induced pluripotent stem cell-derived dendritic cell vaccine therapy genetically modified to express neo-antigen
诱导多能干细胞衍生的树突状细胞疫苗疗法经过基因改造以表达新抗原
- 批准号:
23K08160 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System
通过新型混合生物-生物材料载体系统进行靶向基因递送和人类树突状细胞成熟
- 批准号:
10586414 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Role of glutamine metabolism in Dendritic Cell Development
谷氨酰胺代谢在树突状细胞发育中的作用
- 批准号:
10735230 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:














{{item.name}}会员




